Today, the OpenBiome Foundation announced the unanimous election of its Board Leadership for a three-year term, effective immediately. The officers, representing a cross section of innovators – from the clinical, patient, technology and financial fields – will guide the Foundation in its mission to expand patient access to microbiome therapies and drive scientific discoveries that will shape the future of health.
Patient outcomes may depend on science that’s moving faster than any of us can track. OpenBiome Foundation’s monthly newsletter cuts through the noise – delivering focused conversations with leading researchers and clinicians on the microbiome discoveries most relevant to your practice. The first edition features Dr. L. Clifford McDonald, MD, Associate Director for Science in the Division of Healthcare Quality Promotion (DHQP) at the Centers for Disease Control and Prevention (CDC), one of the foremost experts in Clostridioides difficile (C. difficile) epidemiology.